Lincoln Pharmaceuticals Limited share price
NSE: LINCOLN · ISIN INE405C01035
Key numbers
- Market cap
- ₹ 1,184 Cr
- Current price
- ₹ 591.00
- 52-week high / low
- ₹ 770 / 440
- Stock P/E
- 12.3
- Book value
- ₹ 378.3
- Dividend yield
- 0.30%
- ROCE
- 16.2%
- ROE
- 12.3%
- Debt to equity
- 0.01
- Sales growth (3 yrs)
- 9.5%
- Profit growth (3 yrs)
- 6.4%
- 1-year return
- 6.5%
About Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, anti-infective, anti-bacterial, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics in the form of tablets, capsules, injectables, dry syrups, sprays, ointments etc. It exports its products to Europe, Canada, Latin and North America, Africa, Asia, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 154 | 163 | 166 | 187 | 177 |
| Operating profit | 24 | 25 | 24 | 25 | 27 |
| Net profit | 28 | 20 | 29 | 12 | 36 |
| EPS (₹) | 13.82 | 9.98 | 14.28 | 5.81 | 18.09 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.